Cytotoxicity of Di-rhamnolipids Produced by RA5 Against Human Cancerous Cell Lines
Overview
Affiliations
Rhamnolipid biosurfactant produced by , possesses non-toxicity, environmental compatibility, a wide range of pH (4-8), temperature (4-100 °C), and salinity (1-10%) stability. The application of RLs is worldwide accepted in the pharmaceutical, medicinal, and food industries. It has been used for cytotoxicity efficacy analysis with a limited number of cancerous cell lines. To widen the scope of rhamnolipid application as an anticancer agent, we have studied Di-RLs homolog, 'Rha-Rha-C10-C10' produced by RA5 against human cancerous cell lines including breast cancer (MCF-7), leukemia (K-562), cervical cancer (HeLa), Lung cancer (HOP-62), and colon cancer (HT-29) in a dose-dependent way. It was purified with silica gel chromatography followed by TLC and mass spectroscopy prior to cytotoxicity analysis. With a tensiometer, critical micelle concentration of Di-RLs was estimated to be 33.92 ± 2 mN/m at 0.2%. Cytotoxicity analysis of Di-RLs on K-562 cell line demonstrated inhibition with GI50 and TGI at < 10 µg/mL and 66.6 µg/mL, after 48 h of application. The morphology of human cancerous cell lines was observed under a laser confocal microscope with the SRB staining method. Further research is recommended to comprehend the Di-RLs as a potential anti-cancer agent.
The Physicochemical and Functional Properties of Biosurfactants: A Review.
Dini S, Bekhit A, Roohinejad S, Vale J, Agyei D Molecules. 2024; 29(11).
PMID: 38893420 PMC: 11173842. DOI: 10.3390/molecules29112544.